Welcome to the e-CCO Library!

P337: Early infliximab clearance predicts remission in children with Crohn’s Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Chung, A.(1);Carroll, M.(1);Almeida, P.(1);Petrova, A.(1);Mould, D.(2);Wine, E.(1);Huynh, H.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P337: Efficacy of intravenous cyclosporine in fulminant steroid-refractory ulcerative colitis with massive bleeding: a retrospective, observational study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ogashiwa T., Nishio M., Otake H., Inoue E., Kimura H., Kunisaki R.

Created: Wednesday, 20 February 2019, 10:36 AM
P337: Low seroprevalence of celiac disease in a large screening study in unselected Swiss IBD cohort patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Biedermann on behalf of the Swiss IBD Cohort Study Group1*, F. Wüstholz2, N. Fournier3, T. Greuter2, P. Schreiner2, B. Misselwitz2, J. Zeitz4, M. Scharl2, P. Frei5, E. Safroneeva6, A. Schoepfer7, M. Kaelin8, G. Rogler2, S.R. Vavricka9

Created: Thursday, 21 February 2019, 9:14 AM
P337: Switching from originator infliximab to CT-P13: single-centre experience from the UK
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. P. Bhandare*1, B. Crooks1, G. B. Nigam1, J. K. Limdi1,2

Created: Friday, 22 February 2019, 9:41 AM
P337: Therapeutic drug monitoring: standardization of Promonitor Quick IFX and Promonitor Quick ADL point of care tests with WHO International Standards for the quantification of infliximab and adalimumab in whole blood and serum
Year: 2022
Source: ECCO'22
Authors: Ametzazurra, A.(1);Pascual, J.(1);Del Rio, L.(1);Urigoitia, A.(1);Nagore, D.(1);Ruiz-Argüello, M.B.(1);
Created: Friday, 11 February 2022, 3:52 PM
P338 The effectiveness of a standardised biologic care pathway in the management and treatment of inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Willett1, C.G. Heisler1, N. Nazer1, B. Currie1, K. Phalen-Kelly1, M. Stewart2, J. Jones2

Created: Thursday, 30 January 2020, 10:12 AM
P338: Early proactive drug monitoring strategy of infliximab as monotherapy for inflammatory bowel disease in paediatric patients is associated with good sustained clinical remission
Year: 2022
Source: ECCO'22
Authors: Girard, C.(1);Achkar, S.(2);Sassine, S.(2);Chapuy, L.(3);Jantchou, P.(1);Deslandres, C.(1);
Created: Friday, 11 February 2022, 3:52 PM
P338: effectiveness and safety of biological therapies in elderly inflammatory bowel diseases patients results from a multi center study of Geteccu
Year: 2021
Source: ECCO'21 Virtual
Authors: Suarez Ferrer, C.J.(1);Mesonero , F.(2);Caballol, B.(3);Saiz Chumillas, R.(4);Bastón-Rey, I.(5);Rubin de Celix, C.(6);Melcarne, L.(7);Caballero Mateos, A.(8);Calafat, M.(9);Alonso Galan, H.(10);Vega Villaamil, P.(11);Castro Senosiain, B.(12);Rodriguez Diaz, C.Y.(13);Plaza Santos, R.(14);Marques Cami, M.(15);Rodriguez Grau, M.C.(16);Ramirez, F.(17);Lopez-García, A.(18);Gomez Pastrana, B.(19);Gonzalez Partida, I.(20);Botella Mateu, B.(21);Cuevas del Campo, L.(22);Gonzalez Peña, E.(23);Iyo, E.(24);Elosua Gonzalez, A.(25);Sainz, E.(26);Hernandez, L.(27);Perez Galindo, P.(28);Rueda Garcia, J.L.(29);Martin-Arranz, M.D.(29);Lopez Sanroman, A.(30);Fernandez-Clotet, A.(3);Sicilia, B.(4);Calviño Suárez, C.(5);Mañosa Ciria, M.(9);Barreiro-De Acosta, M.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P338: Long-term complications in patients with fistulising Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Vuyyuru*1, S. Kedia1, P. Sahu1, S. Bopanna1, S. Jain1, G. Makharia1, V. Ahuja1

Created: Friday, 22 February 2019, 9:41 AM
P338: Outcome of hospitalised patients with inflammatory bowel disease complicated by Clostridium difficile infection: Results from a tertiary referral centre
Year: 2018
Source: ECCO '18 Vienna
Authors:

O. Stoica1*, C. Stanciu2, A.-M. Singeap3, I. Girleanu3, S. Chiriac1, C. Muzica1, A. Trifan3

Created: Thursday, 21 February 2019, 9:14 AM
P338: Rate and predictors of mucosal healing in patients with ulcerative colitis treated with thiopurines: results of a multicentric cohort study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

C. Prieux-Klotz*1, S. Nahon2, A. Amiot3, L. Sinayoko4, C. Galéano-Cassaz5, S. Chaussade1, P. Lahmek6, V. Abitbol1

Created: Friday, 22 February 2019, 9:49 AM
P338: Transmural healing is not associated with less disability than complete endoscopic mucosal healing: a prospective study in a patient with Crohn's disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Yzet, C.(1);Brazier, F.(2);Hautefeuille, V.(2);Grados, L.(2);Decrombecque, C.(2);Diouf, M.(3);Fumery, M.(2)*;
Created: Friday, 14 July 2023, 11:05 AM
P338: Value of cross-sectional imaging in assessing active Crohn's disease before stoma reversal
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Dirrenberger B.*1, Clerc-Urmès I.2, Germain A.3, Bresler L.3, Olivera P.1, Martelli L.1, Baumann C.2, Laurent V.4, Peyrin-Biroulet L.1

Created: Wednesday, 20 February 2019, 10:36 AM
P339 Assessment of DNA-thioguanine nucleotide identifies patients at risk of thiopurine-induced leukopoenia in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

X. Zhu1, K. Chao2, X. Gao2, M. Huang1, X.D. Wang1

Created: Thursday, 30 January 2020, 10:12 AM
P339: Application of Bayesian modelling with infliximab to determine optimal patient-specific regimens
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. E. Ritter*1, H. E. SarlesJr2, R. C. McLeay3, L. J. Van Anglen4, C. P. Schroeder4, T. C. Hardin4

Created: Friday, 22 February 2019, 9:41 AM
P339: Crohn’s disease and self-monitoring through a mobile App: The Medicrohn study
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Echarri1*, I. Vera2, J. Guardiola3, R. De Lucas2, V. Ollero1, B. Castro4, F. Gallego5, M. Aguas6, M. Chaparro7, C. Arajol3, P. Robledo8, D. Ceballos9, S. García10, S. Riestra11, I. Marín-Jimenez12, J. Muñiz13, P. Nos6

Created: Thursday, 21 February 2019, 9:14 AM
P339: Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: TheodorakiMD- MA- PhD c, E.(1);Orfanoudaki, E.(1);Foteinogiannopoulou, K.(1);Andreou, N.P.(2);Gazouli, M.(2);Koutroubakis, I.(1);
Created: Friday, 11 February 2022, 3:52 PM
P339: MadCAM1 expression in intestinal lamina propria endothelium varies among inflammatory bowel disease patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Zamborsky T.1,2, Berakova K.3, Kadleckova B.2, Podmanicky D.4, Zelinkova Z.*1

Created: Wednesday, 20 February 2019, 10:36 AM
P339: Pregnant women with perianal Crohn’s Disease: suggestions for the improvement of the current guideline on delivery method
Year: 2021
Source: ECCO'21 Virtual
Authors: Schaafsma, I.(1);Hoogenboom, F.(2);Visschedijk, M.(1);Prins, J.(3);Dijkstra, G.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P339: The efficacy of intravenous iron therapy in IBD patients with active disease is not influenced by the degree of inflammatory activity
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Walper*1, A. Dignass2, 3, J. Stein3, 4

Created: Friday, 22 February 2019, 9:49 AM